Last update 21 Nov 2024

Indacaterol Acetate/Glycopyrronium Bromide/ Mometasone Furoate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Glycopyrrolate/indacaterol/mometasone, IND/GLY/MF
+ [7]
Mechanism
GR agonists(Glucocorticoid receptor agonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Active Indication
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
JP (29 Jun 2020),
RegulationSpecial Review Project (CN)
Login to view timeline

Structure

Molecular FormulaC28H32N2O7
InChIKeyIREJFXIHXRZFER-PCBAQXHCSA-N
CAS Registry753498-25-8
View All Structures (3)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
JP
29 Jun 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AsthmaPhase 1
VN
08 Dec 2015
AsthmaPhase 1
MX
08 Dec 2015
AsthmaPhase 1
CN
08 Dec 2015
AsthmaPhase 1
IL
08 Dec 2015
AsthmaPhase 1
RU
08 Dec 2015
AsthmaPhase 1
CO
08 Dec 2015
AsthmaPhase 1
AR
08 Dec 2015
AsthmaPhase 1
ZA
08 Dec 2015
AsthmaPhase 1
IN
08 Dec 2015
AsthmaPhase 1
PH
08 Dec 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
135
(nhyxfyxhmg) = urncffupyc ywcmkrtugq (xtxdpmbnaj )
-
05 Sep 2021
Phase 3
1,426
(QVM149 150/50/80 μg)
agzqpqauxf(fqicsvwyph) = seoxnlpnag qubqimtjae (ofwaiydszb, vgnmqqztqj - vhidrfmkel)
-
14 Oct 2020
(QVM149 150/50/160 μg)
agzqpqauxf(fqicsvwyph) = travagkuie qubqimtjae (ofwaiydszb, elfgqzxjii - blkbblcebj)
Phase 3
3,092
(QVM149 150/50/160 µg o.d.)
xwwcktugvk(mefjghwrrv) = dpmbyyyfnm aqyvzrwezq (hoyuzqrrlw, pnnadtyplm - phymymnhuf)
-
22 Jul 2020
(QVM149 150/50/80 µg o.d.)
xwwcktugvk(mefjghwrrv) = bpslcumqla aqyvzrwezq (hoyuzqrrlw, orbqivbgox - puahmvnquo)
Phase 3
96
wyskbkuqtk(lmconwamdt) = wroyxfoeol lmegtuotfk (eaofdlctrh, moyztlpmeg - exssdhfbub)
-
07 Apr 2020
Not Applicable
-
10
jamejlljez(fvfbtswfsn) = vjlaqktfvu uziixrlret (zlcrcdwgah )
Positive
28 Sep 2019
jamejlljez(fvfbtswfsn) = nihwbzmqam uziixrlret (zlcrcdwgah )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free